Fact CheckerSign in

NCT06753877Completed

Clinical Monitoring Using ICF

Clinical Monitoring of Individuals With Stroke During Inpatient Rehabilitation Using ICF:A Short-Term Follow-Up Study

Source: ClinicalTrials.gov · Last updated 29 Dec 2025

Brief summary (registry, in English)

The present study examined stroke patients who applied to occupational therapy units within the framework of ICF, following the rehabilitation process, and defining frequently used measurements in terms of ICF codes

Status (registry)
Completed
Study type
Interventional
Enrollment
200 (actual)
First submitted
23 Dec 2024
Start date
1 Jun 2024
Primary completion date
1 Oct 2024
Lead sponsor
Hacettepe University
Diseases
Stroke
NCT number
NCT06753877

What you commit to

  • Study type: Interventional
  • Participants enrolled: 200
  • From 1 Jun 2024 to the primary completion date, 1 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Individuals with orthopedic, psychological or neurological conditions other than stroke that could affect their functioning and those with moderate or severe aphasia were not included in the study

Who the study is looking for

  • Diagnosis of stroke, age between 18 and 64 years,
  • Being served by hospital, being enrolled in the occupational therapy,
  • Volunteering to participate in the study

Age in the registry: 18 years to 64 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Mardin Traning and Rsearch Hospital
Coordinator of this site? Confirm its status
MardinTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.